Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Johnston, Carol S., et al
The FDA approved Wegovy in 2024 specifically to reduce cardiovascular death, heart attack, and stroke risk in this population
Will be purchasing again
Both contain identical tirzepatide molecules but carry different FDA-approved indications which matters significantly for insurance coverage
Among Gen Z, 58% felt uncomfortable discussing weight management goals with HR, 53% were uncomfortable disclosing GLP-1 use, and 38% had kept their efforts private
US$ 26.19
US$ 20.92
US$ 22.00
US$ 25.42
US$ 28.40
US$ 20.41
US$ 29.62
US$ 25.55
